Tyra Biosciences Statistics
Total Valuation
TYRA has a market cap or net worth of $1.90 billion. The enterprise value is $1.52 billion.
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYRA has 59.47 million shares outstanding. The number of shares has increased by 2.05% in one year.
| Current Share Class | 59.47M |
| Shares Outstanding | 59.47M |
| Shares Change (YoY) | +2.05% |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 2.75% |
| Owned by Institutions (%) | 70.79% |
| Float | 30.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.89 |
| P/TBV Ratio | 4.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.49, with a Debt / Equity ratio of 0.01.
| Current Ratio | 20.49 |
| Quick Ratio | 20.05 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.87% and return on invested capital (ROIC) is -24.71%.
| Return on Equity (ROE) | -36.87% |
| Return on Assets (ROA) | -23.64% |
| Return on Invested Capital (ROIC) | -24.71% |
| Return on Capital Employed (ROCE) | -36.38% |
| Weighted Average Cost of Capital (WACC) | 8.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.51M |
| Employee Count | 87 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +231.05% in the last 52 weeks. The beta is 0.75, so TYRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +231.05% |
| 50-Day Moving Average | 32.35 |
| 200-Day Moving Average | 26.64 |
| Relative Strength Index (RSI) | 57.71 |
| Average Volume (20 Days) | 1,214,934 |
Short Selling Information
The latest short interest is 9.87 million, so 16.59% of the outstanding shares have been sold short.
| Short Interest | 9.87M |
| Short Previous Month | 9.28M |
| Short % of Shares Out | 16.59% |
| Short % of Float | 31.95% |
| Short Ratio (days to cover) | 10.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -142.91M |
| Pretax Income | -131.11M |
| Net Income | -131.11M |
| EBITDA | -142.37M |
| EBIT | -142.91M |
| Earnings Per Share (EPS) | -$2.18 |
Full Income StatementBalance Sheet
The company has $383.47 million in cash and $5.70 million in debt, giving a net cash position of $377.77 million or $6.35 per share.
| Cash & Cash Equivalents | 383.47M |
| Total Debt | 5.70M |
| Net Cash | 377.77M |
| Net Cash Per Share | $6.35 |
| Equity (Book Value) | 387.58M |
| Book Value Per Share | 6.52 |
| Working Capital | 375.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$102.26 million and capital expenditures -$215,000, giving a free cash flow of -$102.47 million.
| Operating Cash Flow | -102.26M |
| Capital Expenditures | -215,000 |
| Depreciation & Amortization | 541,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -102.47M |
| FCF Per Share | -$1.72 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |